U.S. flag

An official website of the United States government

NM_000059.4(BRCA2):c.462_463del (p.Arg155_Asp156insTer) AND Breast and/or ovarian cancer

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jun 11, 2019
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001271038.9

Allele description [Variation Report for NM_000059.4(BRCA2):c.462_463del (p.Arg155_Asp156insTer)]

NM_000059.4(BRCA2):c.462_463del (p.Arg155_Asp156insTer)

Gene:
BRCA2:BRCA2 DNA repair associated [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
13q13.1
Genomic location:
Preferred name:
NM_000059.4(BRCA2):c.462_463del (p.Arg155_Asp156insTer)
Other names:
690delAA
HGVS:
  • NC_000013.10:g.32900273_32900274del
  • NC_000013.11:g.32326137_32326138del
  • NG_012772.3:g.15658_15659del
  • NM_000059.4:c.462_463delMANE SELECT
  • NP_000050.3:p.Arg155_Asp156insTer
  • LRG_293:g.15658_15659del
  • NC_000013.10:g.32900273_32900274del
  • NC_000013.10:g.32900274_32900275del
  • NC_000013.10:g.32900274_32900275del
  • NC_000013.10:g.32900274_32900275delAA
  • NM_000059.3:c.461_462del
  • NM_000059.3:c.462_463delAA
  • NM_000059.4:c.462_463del
  • U43746.1:n.690_691delAA
Nucleotide change:
690DELAA
Links:
Breast Cancer Information Core (BIC) (BRCA2): 690&base_change=del AA; dbSNP: rs80359459
NCBI 1000 Genomes Browser:
rs80359459
Molecular consequence:
  • NM_000059.4:c.462_463del - frameshift variant - [Sequence Ontology: SO:0001589]
Observations:
1

Condition(s)

Name:
Breast and/or ovarian cancer
Identifiers:
MedGen: CN221562

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV001451855CZECANCA consortium
no assertion criteria provided
Pathogenic
(Jun 11, 2019) 		germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
Slavicgermlineyes1not providednot providednot providednot providedclinical testing

Citations

PubMed

Multigene Panel Germline Testing of 1333 Czech Patients with Ovarian Cancer.

Lhotova K, Stolarova L, Zemankova P, Vocka M, Janatova M, Borecka M, Cerna M, Jelinkova S, Kral J, Volkova Z, Urbanova M, Kleiblova P, Machackova E, Foretova L, Hazova J, Vasickova P, Lhota F, Koudova M, Cerna L, Tavandzis S, Indrakova J, Hruskova L, et al.

Cancers (Basel). 2020 Apr 13;12(4). doi:pii: E956. 10.3390/cancers12040956.

PubMed [citation]
PMID:
32295079
PMCID:
PMC7226062

Details of each submission

From CZECANCA consortium, SCV001451855.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1Slavic1not providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided1not providednot providednot provided

Last Updated: Sep 8, 2024